A phase II trial of the anti -PD-1 monoclonal antibody Pembrolizumab (MK-3475)+ Lenalidomide + Dexamethasone as post autologous transplant consolidation in patients with high-risk multiple myeloma - Regional Cancer Care Associates LLC

Clinical Trials

A phase II trial of the anti -PD-1 monoclonal antibody Pembrolizumab (MK-3475)+ Lenalidomide + Dexamethasone as post autologous transplant consolidation in patients with high-risk multiple myeloma

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Hackensack UMC
Protocol Number
Hackensack UMC MK-3475-IST (3475-381)
Cancer Diagnosis
To Learn More Call
201-510-0910